			Home About us Contact

Semen Cryopreservation (semen + cryopreservation)

Distribution by Scientific Domains

Medical Sciences	75%

Selected Abstracts

Cryopreservation technique: comparison of Test yolk buffer versus SpermCryo and vapour versus computerised freezing

ANDROLOGIA, Issue 1 2008
L. Paras
Summary Semen cryopreservation offers the possibility to maintain fertility over a long time period e.g. for male cancer patients. Although its use expands worldwide, there is no established method that can be referred to as an entrenched standard for routine laboratory use. Cryodamage is still a general phenomenon and the success of cryopreservation is affected on one side by the cryoprotective agent and on the other side by the technique of freezing. In this methodological study, we compared the newly offered SpermCryo (SC) with the standard used cryoprotectant Test yolk buffer (TYB). We could show that TYB is superior to SC. In addition, we compared the two mainly used techniques for cryopreservation: computerised slow-stage freezing versus nitrogen vapour fast freezing. Regarding the sperm post-thaw motility and viability, no significant difference was found between these two methods. In conclusion, TYB can be recommended as a cryomedium of first choice and the appropriate freezing technique can be selected according to the local facilities of the institution. [source]

Semen cryopreservation in the Salmonidae and in the Northern pike

AQUACULTURE RESEARCH, Issue 3 2000
F. Lahnsteiner
The present paper summarizes the data on a semen cryopreservation method for the Salmonidae (Oncorhynchus mykiss, Salmo trutta f. lacustris, Salvelinus fontinalis, Salvelinus alpinus, Salmo trutta f. fario, Hucho hucho, Coregonus lavaretus, Thymallus thymallus) and for the Northern pike (Esox lucius) published during recent years. It describes (1) methods used for the determination of sperm viability; (2) the protective efficiency of substances specifically for protection of internal and external parts of cells and the process of extender development; (3) the freezing, thawing and fertilization conditions; and (4) the tolerable deviations from the freezing protocol for more easy application. Finally, biomarkers are reported that predict the suitability of semen for cryopreservation and the quality of frozen,thawed semen. [source]

Gonadal dysfunction in male cancer patients before cytotoxic treatment

INTERNATIONAL JOURNAL OF ANDROLOGY, Issue 1 2010
Niels J. Van Casteren
Summary Male patients diagnosed with cancer are often referred for semen cryopreservation before gonadotoxic treatment but often have low semen quality. The aim of this study was to evaluate which type of cancer affects gonadal function and proposes a risk factor for low pre-treatment semen quality. Between January 1983 and August 2006, 764 male cancer patients were referred for semen cryopreservation prior to chemotherapy and radiotherapy. We compared semen characteristics and reproductive hormones between different groups of cancer patients. In addition, we evaluated the role of tumour markers in patients with testicular germ-cell tumours (TGCT) on fertility. Abnormal semen parameters were found in 489 men (64%) before cancer treatment. Patients with TGCT and extragonadal germ-cell tumours had significantly lower sperm concentrations and inhibin B levels than all other patient groups. No semen could be banked in 93 patients (12.2%). Eight hundred and thirty-nine of 927 (90%) produced semen samples were adequate for cryopreservation. Inhibin B in all groups showed to be the best predictor of semen quality. Although pre-treatment raised tumour markers were associated with a decrease in inhibin B and increased follicle stimulating hormone, both predictive for low semen quality; no direct linear association could be found between raised beta-HCG, alfa-fetoprotein and semen quality. Only 1/3 of cancer patients had normal semen parameters prior to cancer treatment. Patients with TGCT and extragonadal GCT have the highest risk for impaired semen quality and gonadal dysfunction at the time of semen cryopreservation. [source]

Effect of pentoxifylline on motility and membrane integrity of cryopreserved human spermatozoa

INTERNATIONAL JOURNAL OF ANDROLOGY, Issue 3 2002
P. Stanic
The purpose of this study was to examine the effects of pentoxifylline used before and after semen cryopreservation,thawing on sperm motility and membrane integrity. Twenty-four semen samples were split into four equal aliquots. Aliquots were incubated at 37 °C for 30 min, followed by cryopreservation with TEST-yolk freezing medium using slow programmable freezing protocol. After 2 weeks the sperm samples were thawed, washed twice in Quinn's Sperm Washing Medium (modified HTF with 5.0 mg/mL Human Albumin) and incubated at 37 °C for 30 min. Aliquots were treated by adding 3 mmol/L pentoxifylline to: (1) fresh sperm samples during incubation period prior to cryopreservation, (2) sperm samples as a supplement to the cryoprotectant prior to cryopreservation, and (3) thawed sperm samples during incubation period. One aliquot received no treatment (control group). The addition of 3 mmol/L pentoxifylline to fresh semen during incubation period prior to cryopreservation significantly decreased progressive and total motility compared with controls. However, the addition of 3 mmol/L pentoxifylline to cryopreserved semen after thawing significantly increased progressive and total motility compared with controls. After post-thaw, no differences in motion characteristics between sperm samples treated by adding 3 mmol/L pentoxifylline as a supplement to the cryoprotectant and control groups were observed. Post-thaw hypoosmotic swelling (HOS) test scores did not improve with the addition of pentoxifylline compared with the control group. It is concluded that pentoxifylline enhanced post-thaw motility of cryopreserved human spermatozoa when added after thawing. No improvement was found by freezing sperm with pentoxifylline. [source]